British drug maker GSK plc (GSK, GSK.L) announced Monday that the U.S. Food and Drug Administration has accepted for review, data ...

IT’S that time of year where we’re greeted by a cacophony of coughs, sneezes and sniffles wherever we go. You might think a cough is a cough, but different conditions will produce a ...

A new way of treating serious asthma and chronic obstructive pulmonary disease (COPD) attacks could be a "game-changer" and lead to the first leap in treatment for 50 years, researchers have said.

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung inflammation. It is currently used as a repeat treatment for severe asthma at a low ...

Some nasal sprays contain oxymetazoline ... can examine the inside of the nose with a light and recommend further testing or treatment if needed. Blood tests may be necessary if a doctor suspects ...

However, if symptoms persist, medical treatment may be required to aid recovery. Acute sinusitis is a new viral or bacterial ... narrow paranasal channels, or nasal polyps may predispose ...

Evaluating a Potential Treatment Adding another dimension to their new study, the Gladstone team used VAME to learn whether a potential therapeutic intervention for Alzheimer's would prevent the ...

Scientists uncover new brain regions supporting social interactions, offering insight into anxiety and depression treatment through a connection to the amygdala. Trending Photos New York: A team of ...

targeted treatments. In a shift from their usual studies on RNA and developmental timing, researchers in the Grosshans lab at the FMI have created a new technique, named qPISA—or "quantitative ...

The preclinical study, published in Cardiovascular Diabetology, found LXA4, which is known for its “calming agent” action in turning off the body’s inflammatory response and preventing chronic ...